question: Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection
answer: The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI.